SCHEMBL18304653

SCHEMBL18304653

Fc1ccc(-c2cccs2)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.50
ERN1 O75460 2/20 0.46
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
LTA4H P09960 1/20 0.43
GHSR Q92847 1/20 0.42
PGR P06401 3/20 0.41
ACLY P53396 2/20 0.41
PDK2 Q15119 1/20 0.41
SLC6A11 P48066 1/20 0.41
FTO Q9C0B1 1/20 0.40
FLT3 P36888 1/20 0.40
PTGS2 P35354 2/20 0.40
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318301 0.82 KCNH2 (0.55) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL1726249 0.82 KCNH2 (0.55) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL16596476 0.79 ERN1 (0.48) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL6300223 0.78 KCNH2 (0.50) KCNH2ERN1MAPTLTA4HPGR
SCHEMBL1133644 0.78 KCNH2 (0.50) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL21999632 0.78 KCNH2 (0.70) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL935142 0.76 LTA4H (0.57) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL29945114 0.76 KCNH2 (0.52) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL6744197 0.76 KCNH2 (0.52) KCNH2ERN1KDM4EMAPTLTA4H
SCHEMBL2368386 0.75 ERN1 (0.51) KCNH2ERN1LTA4HPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307258-B1 ARYL SULFONOHYDRAZIDES UNIV MONASH (AU) 2020-12-16 EP disclosed
EP-3307258-B1 ARYL SULFONOHYDRAZIDES UNIV MONASH (AU) 2020-12-16 EP disclosed
US-10829446-B2 Aryl sulfonohydrazides MONASH UNIVERSITY (AU) 2020-11-10 US disclosed
US-10829446-B2 Aryl sulfonohydrazides MONASH UNIVERSITY (AU) 2020-11-10 US disclosed
US-20180222857-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2018-08-09 US disclosed
US-20180222857-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2018-08-09 US disclosed
US-20180222857-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2018-08-09 US disclosed
EP-3307258-A1 ARYL SULFONOHYDRAZIDES Monash University (AU) 2018-04-18 EP disclosed
WO-2016198507-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2016-12-15 WO disclosed
WO-2016198507-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2016-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222857-A1 ARYL SULFONOHYDRAZIDES FPR3, NCOA3, HAT1 KCNH2 2509/4885ERN1 1510/4885KDM4E 2042/4885
US-10829446-B2 Aryl sulfonohydrazides FPR3, NCOA3, HAT1 KCNH2 2509/4885ERN1 1510/4885KDM4E 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.